|
Publish date: May, 2006
Code: P1610
Language: English
Price: 2950 Euro
Abstract
The European pharmaceutical market is currently hampered by the overall sluggish economy and the government measures to limit pharmaceutical expenditures. The sales grew 6% to reach 165 in 2004, and are predicted to even slow down to 5% over the next two years as the economy stagnates. While the aging population, earlier diagnosis and recognition of diseases, accession to previously untapped patient groups are strong drivers to push the whole market forward.
The European pharmaceutical market is regionally diverse in terms of pricing, funding, domestic production and health care policy. As generic substitution is taken as central to cost control by the governments, the generics sector is set to grow rapidly and will continually take the market share from patented drugs.
The study presents pharmaceutical sales and trends through 2010 to 2015, reviews leading products and therapeutic categories, examines government regulations and R&D trends, analyses key market players and outlines the competition landscape, and evaluates market chances and risks.
Table of Contents
I. Executive Summary
II. Macro environment of the European Pharmaceutical Market
a) Demographic Pattern
b) Health Care Environment
c) Leading causes of death
d) Regulatory Environment
e) Pricing and reimbursement regulations
f) Innovations and R&D trends
g) Marketing and promotion of drugs
III. Overview of the European pharmaceutical market
a) Market definition and segmentation
b) Market size and forecast
European market of pharmaceuticals by regions 2004-2015
European market of pharmaceuticals by therapeutic category 2004-2015
Leading drug categories
Leading pharmaceutical companies
Leading products European market of pharmaceuticals by type 2004-2015
c) Market development of generics
d) Market development of biopharmaceuticals
e) Pharmaceuticals distribution channels
f) Import & Export
IV. Market analysis by region
Germany
Market overview and forecast
Health care indicators
Market by therapeutic categories Demographic pattern
Healthcare system and End user analysis
Import & export
Chances and risks France
Market overview and forecast
Health care indicators
Market by therapeutic categories Demographic pattern
Healthcare system and End user analysis
Import & export
Chances and risks UK
Market overview and forecast
Health care indicators
Market by therapeutic categories Demographic pattern
Healthcare system and End user analysis
Import & export
Chances and risks Italy
Market overview and forecast
Health care indicators
Market by therapeutic categories Demographic pattern
Import & export
Chances and risks Switzerland
Market overview and forecast
Demographic pattern
Market regulations
Import & export
Chances and risks Benelux
Market overview and forecast
Demographic pattern
Import & export
Chances and risks Scandinavian countries
Market overview and forecast
Demographic pattern
Import & export
Chances and risks South Europe (Spain, Portugal, Greece)
Market overview and forecast
Demographic pattern
Market regulations
Import & export
Chances and risks East Europe
Market overview and forecast
Demographic pattern
Import & export
Chances and risks
IV. Market analysis by therapeutic category
Oncology / Cancer
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
Cardiovascular disease
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
Central nervous system
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
GastroIntestinal
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
Infectious
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
Metabolism / diabetes
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
Musculo-skeletal disease
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
Respiratory
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
Haematology
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
Ophthalmics
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
Dermotologics
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
Urogenital
Diseases and Conditions
Treatment and Products
Market size and forecast
Market drivers and restrains
Competition landscape and major participants
VI. Company Profile
|
Market Reports 
